Individuals diagnosed with thyroid nodules or thyroid carcinoma (TC) are normally not thought to be at a higher risk of getting SARS-CoV-2 than the general population since they have previously been sent for testing and treatment. This is because they have been immunosuppressed previously. Nevertheless, efforts should be made to give medical aid in the most efficient manner possible during a pandemic. Even while there are numerous thyroid nodules and only a small percentage of them are malignant, the overwhelming majority of thyroid tumors are benign. This is despite the presence of several thyroid nodules. During the current SARS-CoV-2 epidemic, it is suggested that both radioiodine therapy and thyroid surgery for the treatment of benign or malignant thyroid nodules be suspended. In order to ensure a timely diagnosis and, if necessary, treatment, patients should be taught all they need to know and be continuously on the lookout for warning signs. Additionally, patients should constantly be aware of any warning indications. Despite the risk of COVID19 and SARS-CoV-2 infection, diagnostic procedures (such as ultrasonography, scintigraphy, and fine-needle aspiration), surgical procedures, and radioiodine therapy may be performed; however, each case must be evaluated individually to determine whether these procedures are appropriate.